Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
about
Oral insulin delivery: how far are we?Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetesProbing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation.Characterization of biologically active insulin-loaded alginate microparticles prepared by spray drying.Bimodal visualization of colorectal uptake of nanoparticles in dimethylhydrazine-treated mice.Novel preparation of PLGA/HP55 nanoparticles for oral insulin delivery.Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering.Nanoparticle strategies for the oral delivery of insulin.Detecting and treating cancer with nanotechnology.Modulation of cultured neural networks using neurotrophin release from hydrogel-coated microelectrode arraysMultifunctional Composite Microcapsules for Oral Delivery of Insulin.Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.Composite alginate microspheres as the next-generation egg-box carriers for biomacromolecules delivery.Drug transport mechanism of oral antidiabetic nanomedicines.Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art.Novel drug delivery system: an immense hope for diabetics.Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery.Novel thermogelling dispersions of polymer nanoparticles for controlled protein release.A Novel Approach for Oral Delivery of Insulin via Desmodium gangeticum Aqueous Root Extract.Microencapsulation of insulin using a W/O/W double emulsion followed by complex coacervation to provide protection in the gastrointestinal tract.Developments in polymeric devices for oral insulin deliveryImpact of the in vitro gastrointestinal passage of biopolymer-based nanoparticles on insulin absorptionInsulin-loaded PLGA microparticles: flow focusingversusdouble emulsion/solvent evaporation
P2860
Q24632900-2635A9BE-7881-4715-81A8-22E3F62B1CE0Q26779447-B71426CD-641A-422C-80AD-DD0B5F906211Q30379795-1785E9CD-7052-485E-A906-582B346CAABCQ30413988-F5862D53-4BE8-49F6-84C8-9E7A0DE223B6Q34046035-B65CBEDA-69AB-4F71-840A-B449E5DD12A3Q36218161-2A23F810-3692-4476-AE06-72415D5F7F4DQ36590092-28FF9A15-EE0A-4BCD-8570-03F18412CA5FQ37039026-020C7098-7E72-4B2E-A461-01805373F5CCQ37089855-76CCB325-DEE8-4598-A559-D774CD5DED42Q37399384-5EB4F3D1-FA72-4AE1-A5B7-3AA421EF6177Q37631458-3C20D4B1-E498-4D91-8AD3-C3CE93366EEBQ37948968-819814C3-6DA0-4D05-A70B-5A7B9E202740Q38104796-CA0EDD5A-8D69-4133-9630-8793DD93ACA1Q38201717-05FAF86A-DD9E-4150-8647-2E76F16733C5Q38237646-91A064ED-9127-4FCE-9852-B12C385B7508Q38302000-9120CE1F-9E74-45D8-8FAE-D4B2FE0141DFQ39212810-92E10B89-565D-4B30-9A76-B8F1FFE26B96Q42191686-4A0B16B5-41AA-43BA-B8A8-84257CD6F9C2Q42251233-B6B097CB-D7AA-4B42-B573-9B8893D5C45AQ53582565-72D890F9-AC9C-4C76-8E4D-A12D7B6F6F98Q57349681-6068A8CA-13D5-49BD-A6FD-4054F363E30AQ57570696-5F660F76-E031-4A28-8245-CEA1140A6A79Q58854686-1E6042CB-B716-468C-8194-A74101E54FA7
P2860
Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Nanoparticulate delivery syste ...... in vitro/in vivo bioactivity.
@ast
Nanoparticulate delivery syste ...... in vitro/in vivo bioactivity.
@en
Nanoparticulate delivery syste ...... in vitro/in vivo bioactivity.
@nl
type
label
Nanoparticulate delivery syste ...... in vitro/in vivo bioactivity.
@ast
Nanoparticulate delivery syste ...... in vitro/in vivo bioactivity.
@en
Nanoparticulate delivery syste ...... in vitro/in vivo bioactivity.
@nl
prefLabel
Nanoparticulate delivery syste ...... in vitro/in vivo bioactivity.
@ast
Nanoparticulate delivery syste ...... in vitro/in vivo bioactivity.
@en
Nanoparticulate delivery syste ...... in vitro/in vivo bioactivity.
@nl
P2093
P1476
Nanoparticulate delivery syste ...... in vitro/in vivo bioactivity.
@en
P2093
António J Ribeiro
Ronald J Neufeld
Simone Houng
P304
P356
10.1016/J.EJPS.2006.12.007
P407
P577
2007-01-13T00:00:00Z